Provided by Tiger Fintech (Singapore) Pte. Ltd.

Phathom Pharmaceuticals

3.14
+0.850037.12%
Post-market: 3.240.1000+3.18%19:59 EDT
Volume:12.64M
Turnover:41.67M
Market Cap:218.70M
PE:-0.60
High:3.78
Open:2.33
Low:2.33
Close:2.29
Loading ...
May 26, 2020

Major Issues Report

8-K - Current report
May 12, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 12, 2020

Major Issues Report

8-K - Current report
May 05, 2020

Major Issues Report

Current report, item 1.01
Mar 19, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 19, 2020

Major Issues Report

Current report, items 2.02, 5.02, and 9.01
Mar 17, 2020

Major Issues Report

Current report, items 1.01, 2.03, and 5.02
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 13, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Feb 10, 2020

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Jan 27, 2020

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 02, 2019

Major Issues Report

Current report, items 3.01, 5.02, 8.01, and 9.01
Nov 25, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 25, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 08, 2019

Beneficial Ownership Change

Statement of acquisition of beneficial ownership by individuals
Nov 06, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership
Nov 06, 2019

Beneficial Ownership Change

General statement of acquisition of beneficial ownership